Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages

Conferences and Medical Updates

DDW update by Dr. Maheshwari 2016

                i.         EUS based Hepatic vein portal gradient – first humanized trial done with success.  Use – for example Renal transplant patient with cirrhosis. Poor outcome if gradient more than 12

              ii.         Doppler Endoscopic probe :  Used to assess efficacy of variceal bleed banding

             iii.         C diff : Overall cure rate with FMT is 82%, cure rate for recurrent CDI with colonoscopy was 87% compared to UGI instillation was 69%.  Data from Openbiome, Meford Ma

             iv.         Recurrent CDI was not higher if patients were on PPI / acid suppression

              v.         Metaanalysis showed robust efficacy of prevention of CDI with use of probiotics.   Strains and dose not yet clear.